Indeed, the AKAP1 overexpression strategy has demonstrated therapeutic benefits by restoring mitochondrial homeostasis in several diseases, including diabetic kidney disease, glaucoma, and diabetic cardiomyopathy [24,25,52]. Here, AKAP1 is linked to glaucoma.